Table 2 Summary of multivariable logistic regression models evaluating relationship between each chorioretinal metric (total macular volume and choroidal thickness [locations I, II and III]) and the primary outcomes of a decline in eGFR of ≥10 at 1 year and ≥20% at 2 years

From: Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment

 

Standard error

z-value

OR

Lower

95% CI

Upper

95% CI

p

Residual deviance

Decline in eGFR of ≥10% at 1 year

 Total macular volume (per 1 mm3 decrease)

0.424

−2.08

2.42

1.07

5.70

0.041

240 on 195 df

 Choroid (location I) (per 10 μm decrease)

0.002

−0.30

1.01

0.97

1.05

0.763

244 on 195 df

 Choroid (location II) (per 10 μm decrease)

0.002

−0.99

1.02

0.98

1.06

0.326

243 on 195 df

 Choroid (location III) (per 10 μm decrease)

0.002

−2.38

1.06

1.01

1.11

0.026

238 on 195 df

Decline in eGFR of ≥20% at 2 years

 Total macular volume (per 1 mm3 decrease)

0.492

−1.79

2.42

0.94

6.57

0.071

175 on 150 df

 Choroid (location I) (per 10 μm decrease)

0.002

−0.22

1.01

0.96

1.05

0.821

177 on 149 df

 Choroid (location II) (per 10 μm decrease)

0.002

0.38

0.99

0.95

1.04

0.705

177 on 149 df

 Choroid (location III) (per 10 μm decrease)

0.003

−1.32

1.04

0.98

1.09

0.198

175 on 149 df

  1. Two sided analyses. Models were adjusted for patient age, sex, and baseline renal function, systolic blood pressure and urinary PCR.
  2. CI confidence interval, df degrees of freedom, eGFR estimated glomerular filtration rate, OR odds ratio.